Quantcast Cancer News
Cancer News By sherri.place
Cancer News >> BIOTECH November 26, 2009 members login here
>>  BIOTECH
Health Canada/Information Update: Foreign Particles Found in Certain Products From
Reuters - 86 Minutes ago
OTTAWA, ONTARIO, Nov 26 (MARKET WIRE) -- Health Canada is informing health care professionals and Canadians that routine quality control testing has discovered foreign particles in a small number of vials
     Add Comment

Opposition to GM food 'based on emotion'
Telegraph - 8 Hours ago
Public opposition to genetically modified food is based on emotion rather than reason, a Food Standards Agency report which will help shape future Government policy claims. A protest against GM crops
     Add Comment

Opponents of GM crops are motivated by "emotion" not scientific reason
Telegraph - 8 Hours ago
Opponents of GM food are motivated by emotion and ideology rather than a reasoned scientific approach, according to a major report by a government funded quango. The study, which states one of its aims
     Add Comment

GM crop sceptics 'emotional', Government food watchdog report claims
Telegraph - 9 Hours ago
Public opposition to genetically modified food is based on â??emotionâ? rather than â??reasonâ?, a Food Standards Agency report which will help shape future Government policy claims. The study published
     Add Comment

Gilead and GSK Enter Asian Hepatitis Market
Pharmaceutical Technology - 5 Hours ago
Gilead Sciences and GlaxoSmithKline have announced a licensing agreement to commercialise Viread to treat chronic hepatitis B (HBV) infection in adults in five Asian countries. Under the agreement, Gilead
GSK and Gilead Sciences sign licensing agreement - Zibb.com Zibb
GSK, Gilead enter licensing pact to commercialise HB V drug Viread in 5 Asian countries PharmaBiz
all 4 news articles >>      Add Comment

Experimental Diabetes Mellitus Exacerbates Tau Pathology in a Transgenic Mouse Model
Bioscience Technology Online - 93 Minutes ago
Diabetes mellitus (DM) is characterized by hyperglycemia caused by a lack of insulin, insulin resistance, or both. There is increasing evidence that insulin also plays a role in Alzheimer's disease (AD)
     Add Comment

Genome-wide gene regulation of biosynthesis and energy generation by a novel transcriptional
Bioscience Technology Online - 9 Hours ago
Mono-ubiquitylation of a transactivator is known to promote transcriptional activation of certain transactivator proteins. For the Sacchromyces cerevisiae transactivator, GAL4, attachment of mono-ubiquitin
     Add Comment

UPS and Genzyme are about to go live on a California- and GS1-compliant track-and-trace
Pharmaceutical Commerce - 11 Hours ago
UPS gets ready to receive GS1 product-tracking data from anyone Give the parties involved in this project this credit: they stuck to their guns. UPS Healthcare Logistics (Atlanta), Genzyme (Cambridge,
     Add Comment

Genome Analysis Centre issues capacity and capability challenge
Cambridge Network - 15 Hours ago
Cambridge Network keeps you informed of all the latest news from Cambridge and beyond. News articles posted on our site by our members are picked up by Search engines and News Services such as GoogleNews
     Add Comment

Cephalon Settles Barr Challenge
Individual.com - 39 Minutes ago
Earlier this month, Cephalon Inc. (CEPH) announced that it has settled its patent infringement case with Barr Pharmaceuticals, which is now owned by Teva Pharmaceutical (TEVA). Barr was looking to market
     Add Comment

Public â??confusedâ?? over GM crops
Farmers Weekly Interactive - 104 Minutes ago
Consumers want more information about genetically modified crops, reveals a study. Research conducted on behalf of the Food Standards Agency found different levels of understanding about GM food. Attitudes
     Add Comment

Bayer CropScience Signs Agreement with GVK Biosciences on early-stage Research Projects
United News of India - 116 Minutes ago
Source : GVK Biosciences Private Limited (Business Wire India) Category : BUSINESS, LEISURE, HEALTH Bayer CropScience and GVK Biosciences Private Limited (GVK BIO), Hyderabad, India, have entered into
GVK Bio inks pact with Bayer for early-stage research projects PharmaBiz
Bayer CropScience Signs Agreement with GVK Biosciences on Early-S... Zibb
all 6 news articles >>      Add Comment

Report Exploring Attitudes to GM Food Published
Food Ingredients First - 5 Hours ago
Source:Food Ingredients First Sector:General Company & Ingredient Information Summary:The FSA commissioned this work to complement a series of questions on food technologies, including GM foods, in the
     Add Comment

Sinovac Biotech Ltd announces formation of joint venture for human-use vaccine
M2 - 5 Hours ago
Vaccine company Sinovac Biotech Ltd (Nasdaq:SVA) said on Wednesday that the company has entered into a joint venture (JV) agreement with the Dalian Jin Gang Group to establish the Sinovac (Dalian) Vaccine
Sinovac Biotech Ltd. (SNVBF) Establishes Joint Venture to Expand Human-Use Vaccine BioSpace
all 1 news articles >>      Add Comment

BioTech Capital buys back 4k shares
Business Spectator - 7 Hours ago
Source: News Bites BioTech Capital Ltd bought back 4,000 shares for $1,080 on-market on November 25, 2009. Previously 1,000,000 shares have been bought back. There are 6,979,977 shares still to be bought
     Add Comment

Genzyme CEO sells 200,000 of company's shares
Imaging Economics - 7 Hours ago
BANGALORE (Reuters) - Biotechnology company Genzyme Corp's Chief Executive Henri Termeer sold 200,000 shares of the company for $50.47 apiece on Nov. 23, according to a regulatory filing. In the filing
Genzyme CEO Termeer Sells Company Shares FOXNews.com
all 1 news articles >>      Add Comment

PicksThatMove.com Announces Investment Opinion on Ivernia Inc.,
Business Wire via MSN Money - 7 Hours ago
PicksThatMove is pleased to bring investors special situation stocks which have a high potential for price appreciation. These companies have interesting business models and they have to execute on the
PicksThatMove.com Announces Investment Opinion on Ivernia Inc., Weatherford International Fort Mills Times
PicksThatMove.com Announces Investment Opinion on Bristol-Myers Squibb Co., Incyte SmartBrief
all 4 news articles >>      Add Comment

Biotechnology must be introduced to the young -- DoST
Individual.com - 8 Hours ago
The Department of Science and Technology is aiming to 'popularize' the concept of biotechnology to elementary and high school students to debunk 'misinformation' about the scientific field which can resolve
     Add Comment

Researchers at Signature Genomics Attribute Diverse Spectrum of Neurological Problems
Pharma Live - 8 Hours ago
- Researchers at Signature Genomic Laboratories, which performs diagnostic genetic testing of chromosome abnormalities in individuals with unexplained physical and developmental disabilities, including
     Add Comment

WaferGen to Introduce New Service for Gene-Expression Profiling Using the SmartChip
Pharma Live - 8 Hours ago
FREMONT, Calif., Nov. 19 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. ( OTC:WGBS) (BULLETIN BOARD: WGBS) , a leading developer of state-of-the-art genetic analysis systems, today announced a new,
OncoVista (OVIT.PK) Reports on Gene Expression Profiling Study in Circulating Tumor Business Wire
OncoVista (OVIT.PK) Reports 179% Increase in 3Q Revenues Due to Subsidiary's Proprietary Pharma Live
all 4 news articles >>      Add Comment

FMC Corporation Executives to Address Investors at December Conferences
KOTA Territory News - 9 Hours ago
PHILADELPHIA, Nov. 25 /PRNewswire-FirstCall/ -- FMC Corporation (NYSE: FMC) announced today that it will be presenting at two investor conferences in December at which its executives will provide an overview
Monsanto executives to address investors at December events Your Industry News
QLogic Executives to Present at December Investor Conferences QLogic
all 2 news articles >>      Add Comment

Echo Therapeutics to Present at the New York Society of Security Analysts' 13th
KOTA Territory News - 10 Hours ago
FRANKLIN, Mass., Nov. 24 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal
Emisphere Technologies to Present at the New York Society of Security Analysts 13th Pharmacy Choice
Emisphere Technologies to Present at the New York Society of Security Analysts` Reuters
all 4 news articles >>      Add Comment

Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and
KOTA Territory News - 10 Hours ago
SAN DIEGO, Nov. 24 /PRNewswire/ -- Ambit Biosciences Corporation announced today that there will be multiple presentations evaluating AC220, a novel second generation FLT3 inhibitor, in AML at the 51st
Ambit Biosciences presents data evaluating FLT3 inhibitor in AML at the 51st ASH News-Medical.Net
Ym Biosciences Reports First Patient In Phase I/Ii Trial Of Jak1/Jak2 INHIBITOR, RBC Dain Rauscher
all 2 news articles >>      Add Comment

Sigma-Aldrich to Present at the NASDAQ OMX 23rd Investor Program on Tuesday, December
KOTA Territory News - 10 Hours ago
ST. LOUIS, Nov. 24 /PRNewswire-FirstCall/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) will be presenting at the NASDAQ OMX conference on Tuesday, December 1st at 1:45 PM GMT in London, 7:45 AM US/CST.
Affymetrix to Webcast Presentation at the 23rd NASDAQ OMX Investor Forum Pharma Live
Polycom to Present at NASDAQ OMX 23rd Investor Program and Credit Suisse Annual TradingMarkets
all 9 news articles >>      Add Comment

Novartis Corporation (NVS) (JOBS) Strikes Potential $1.1 Billion Licensing Deal
BioSpace - 11 Hours ago
Potential $1.1 Billion Licensing Deal with , , gaJsHost (('https:' ? 'https://ssl.' : + gaJsHost + 'googleanalytics.com/ga.js' pageTracker BioSpace Enter your BioSpace account email address and password
     Add Comment

Already a member? Sign in
Email Address:
Password:
Forget your password?

Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms of Use   |   Privacy Policy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.